LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Carisma Therapeutics (NASDAQ: CARM)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CARM Carisma Therapeutics
Klichinsky Michael / officer: Chief Scientific Officer
01/28/2025
Buy
$0.50
221,000
$111K
221,000
NASDAQ CARM Carisma Therapeutics
Kelly Steven / director, officer: President and CEO
01/28/2025
Buy
$0.50
500,000
$250K
500,000